Novo Seeks To Toss Antitrust Claims in Prandin Suit
Pharmaceutical company Novo Nordisk Inc. has asked a judge to toss antitrust claims made by generic-drug maker Paddock Laboratories Inc. in an infringement dispute over Novo's diabetes drug Prandin, saying it...To view the full article, register now.
Already a subscriber? Click here to view full article